VPAC2 Receptor Neurons
Overview
VPAC2 receptor neurons represent a functionally distinct neuronal population defined by the expression of the vasoactive intestinal peptide (VIP) receptor 2, encoded by the VIPR2 gene. These neurons are distributed throughout the central and peripheral nervous systems, with particularly high concentrations in the cerebral cortex, hippocampus, cerebellum, and retina. VPAC2 (also known as VPAC₂ or VIP receptor type 2) is a G-protein coupled receptor (GPCR) that responds to VIP, a neuropeptide with pleiotropic neuromodulatory functions. VPAC2 receptor neurons comprise a heterogeneous population including certain GABAergic interneurons, some dopaminergic neurons, and various other neuronal subtypes distinguished by their capacity to respond to VIP signaling. These neurons play critical roles in neural circuit regulation, synaptic plasticity, and circadian rhythm generation, making them particularly vulnerable to dysfunction in several neurodegenerative conditions.
Function/Biology
...VPAC2 Receptor Neurons
Overview
VPAC2 receptor neurons represent a functionally distinct neuronal population defined by the expression of the vasoactive intestinal peptide (VIP) receptor 2, encoded by the VIPR2 gene. These neurons are distributed throughout the central and peripheral nervous systems, with particularly high concentrations in the cerebral cortex, hippocampus, cerebellum, and retina. VPAC2 (also known as VPAC₂ or VIP receptor type 2) is a G-protein coupled receptor (GPCR) that responds to VIP, a neuropeptide with pleiotropic neuromodulatory functions. VPAC2 receptor neurons comprise a heterogeneous population including certain GABAergic interneurons, some dopaminergic neurons, and various other neuronal subtypes distinguished by their capacity to respond to VIP signaling. These neurons play critical roles in neural circuit regulation, synaptic plasticity, and circadian rhythm generation, making them particularly vulnerable to dysfunction in several neurodegenerative conditions.
Function/Biology
VPAC2 receptor neurons integrate VIP-mediated signaling within neural circuits where they modulate both excitatory and inhibitory neurotransmission. Upon VIP binding, VPAC2 activates heterotrimeric G-proteins (primarily Gαs), leading to increased adenylyl cyclase activity and elevated intracellular cyclic AMP (cAMP) levels. This second messenger cascade activates protein kinase A (PKA) and other downstream effectors, ultimately modulating neuronal excitability, neurotransmitter release, and gene expression. In the hippocampus, VPAC2-expressing interneurons, particularly parvalbumin-positive (PV+) fast-spiking basket cells, regulate the timing and synchronization of pyramidal neuron firing through VIP-dependent disinhibition—a mechanism where VIP suppresses GABA release from inhibitory interneurons, thereby disinhibiting principal neurons. In the cerebral cortex, VPAC2+ neurons participate in attention-related circuit modulation and sensory gating. Cerebellar VPAC2+ neurons regulate Purkinje cell activity and contribute to motor coordination and learning. Additionally, VPAC2 receptor neurons in the suprachiasmatic nucleus (SCN) are essential for circadian rhythm generation and entrainment to environmental light-dark cycles.
Role in Neurodegeneration
VPAC2 receptor neurons demonstrate significant vulnerability in multiple neurodegenerative diseases. In Alzheimer's disease (AD), VPAC2-expressing neurons, particularly VIP+ interneurons in the hippocampus and cortex, undergo selective degeneration and show reduced VIP expression. This loss disrupts synaptic inhibition and contributes to network hyperexcitability, which accelerates cognitive decline and promotes tau and amyloid-beta pathology. In Parkinson's disease (PD), VPAC2+ dopaminergic neurons in the substantia nigra are vulnerable to alpha-synuclein-induced toxicity, and loss of VIP signaling impairs dopaminergic neurotransmission. In Huntington's disease (HD), striatal VPAC2+ neurons are among the early targets of mutant huntingtin toxicity, leading to motor and cognitive symptoms. Additionally, circadian rhythm disturbances in neurodegenerative diseases correlate with SCN VPAC2 neuron dysfunction. Age-related oxidative stress, proteostatic failure, and neuroinflammation selectively impact VPAC2+ populations, potentially due to their high metabolic demands and dependence on specific trophic signals.
Molecular Mechanisms
VPAC2 receptor dysfunction in neurodegeneration involves multiple convergent pathways. Amyloid-beta and tau pathology can impair VPAC2 receptor signaling through receptor phosphorylation, desensitization, and internalization. Mitochondrial dysfunction and oxidative stress compromise the metabolic capacity of VPAC2+ neurons to sustain cAMP signaling. Proteostatic collapse leads to accumulation of misfolded receptor protein and impaired VIP ligand availability. Neuroinflammatory mediators (TNF-α, IL-1β) downregulate VPAC2 expression through NF-κB signaling. Loss of trophic support, particularly reduced VIP production by remaining healthy neurons, creates a downward spiral of VPAC2+ neuron vulnerability. Altered calcium homeostasis, impaired mitochondrial ATP production, and defective autophagy specifically compromise GABAergic VPAC2+ interneurons, disrupting inhibitory control and precipitating network dysfunction.
Clinical/Research Significance
VPAC2 receptor-targeted therapeutics represent emerging neuroprotective strategies. VIP analogs and VPAC2 receptor agonists show promise in preclinical models for enhancing synaptic plasticity, reducing neuroinflammation, and promoting neuroprotection. Compounds like BAY 55-9921 have demonstrated efficacy in preserving VPAC2+ neuron function. Understanding VPAC2 neuron vulnerability informs biomarker development for early disease detection and stratification. Preservation or restoration of VPAC2
See Also
- [Principal Pars Compacta](/wiki/cell-types-principal-pars-compacta) — associated_with
- [Principal Pars Compacta](/wiki/cell-types-principal-pars-compacta) — expressed_in
- [Principal Pars Compacta](/wiki/cell-types-principal-pars-compacta) — inhibits
- [ADAM10 — A Disintegrin And Metalloproteinase Domain 10](/wiki/genes-adam10) — inhibits
Pathway Diagram
The following diagram shows the key molecular relationships involving VPAC2 Receptor Neurons discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)